<qa>  What is the effect of the dose concentration and administration frequency of Anecortave AThe purpose of this study was to evaluate the effect of the dose concentration and administration frequency of Anecortave Acetate AA on visual acuity VA and lesion size when administered by posterior juxtascleral depot PJD every 3 months AA 15 mg or 6 months AA 15 mg, AA 30 mg in patients with exudative age-related macular degeneration AMD. 